HIGHLIGHTS
- who: Romain Mustière and colleagues from the (UNIVERSITY) have published the research work: Plasmodial Kinase Inhibitors Targeting Malaria: Recent Developments, in the Journal: (JOURNAL)
- what: __SECTION__ Conclusions.
- how: The research was conducted on articles published from 1 January 2005 to 1 August 2020.
- future: The only thing that prevents PfCDPK4 inhibitors from entering more advanced pre-clinical studies is the long-term bioavailabilitythey theywould would need need to be active studies is the long-term bioavailability active against againstgametocytes. gametocytes.Moreover Moreover studies is the long-term bioavailability they would . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.